日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hybrid molecule SA-10 and its PLGA nanosuspension protect human and rodent retinal ganglion cells against neuronal injury.

混合分子 SA-10 及其 PLGA 纳米悬浮液可保护人类和啮齿动物视网膜神经节细胞免受神经元损伤

Pham Jennifer H, Zhang Wei, Le Kim-Tuyen T, Kodati Bindu, Amankwa Charles E, DebNath Biddut, Johnson Gretchen A, Bui Thien T, Gitter Rachel Y, Gutierrez Jonah P, Hatfield Brendon R, Satyal Rojan, Sinnott Ella R, Krishnamoorthy Raghu R, Acharya Suchismita, Stankowska Dorota L

A Reduction in Mitophagy Is Associated with Glaucomatous Neurodegeneration in Rodent Models of Glaucoma.

线粒体自噬减少与青光眼啮齿动物模型中的青光眼性神经退行性变有关

Chaphalkar Renuka M, Kodati Bindu, Maddineni Prabhavathi, He Shaoqing, Brooks Calvin D, Stankowska Dorota L, Yang Shaohua, Zode Gulab, Krishnamoorthy Raghu R

Role of Glucocorticoids and Glucocorticoid Receptors in Glaucoma Pathogenesis

糖皮质激素及其受体在青光眼发病机制中的作用

Patel, Pinkal D; Kodati, Bindu; Clark, Abbot F

Therapeutic Potential of Antioxidants and Hybrid TEMPOL Derivatives in Ocular Neurodegenerative Diseases: A Glimpse into the Future

抗氧化剂和TEMPOL杂化衍生物在眼部神经退行性疾病中的治疗潜力:展望未来

Amankwa, Charles E; Kodati, Bindu; Donkor, Nina; Acharya, Suchismita

Role of mitophagy in ocular neurodegeneration

线粒体自噬在眼部神经退行性疾病中的作用

Brooks, Calvin D; Kodati, Bindu; Stankowska, Dorota L; Krishnamoorthy, Raghu R

Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases

CRISPR/Cas9基因编辑技术在眼科疾病治疗中的应用

Sundaresan, Yogapriya; Yacoub, Sam; Kodati, Bindu; Amankwa, Charles E; Raola, Akash; Zode, Gulab

Neuroprotective Effects of Transferrin in Experimental Glaucoma Models.

转铁蛋白在实验性青光眼模型中的神经保护作用

Youale Jenny, Bigot Karine, Kodati Bindu, Jaworski Thara, Fan Yan, Nsiah Nana Yaa, Pappenhagen Nathaniel, Inman Denise M, Behar-Cohen Francine, Bordet Thierry, Picard Emilie